Effect of L-lysine on nitric oxide production in ovine endotoxaemia

Excess production of nitric oxide contributes to the refractory hypotension associated with sepsis and is dependent upon precursor availability, L-arginine. Endothelial uptake of L-arginine by the y(+) transporter can be inhibited by another cationic amino acid, L-lysine. This study was undertaken to determine the effects of L-lysine in an anaesthetized ovine model of endotoxaemia in which nitric oxide production is known to be limited by L-arginine availability. The haemodynamic effects of i.v. L-lysine (500 mg kg(-1)) were compared with those of a known inhibitor of nitric oxide synthase, N-G-nitro-L-arginine-methyl ester, L-NAME (25 mg kg(-1)) and with control animals (n=6 per group). Serum nitrates, the stable end metabolite of nitric oxide production, were also measured. L-NAME administration caused a significant increase in systemic and pulmonary vascular resistance (P<0.0001), mean arterial pressure (P<0.0001) and a reduction in serum nitrate concentrations (P<0.0001). The administration of L-lysine had no effect on systemic or pulmonary vascular resistance, mean arterial pressure or serum nitrate concentrations. We conclude that the administration of L-lysine does not inhibit nitric oxide production in this model.